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The use of noninvasive positive pressure ventilation (NPPV) in acute care settings has 
drastically increased within the past 20 years. Research has indicated that NPPV is equally as 
effective as traditional mechanical ventilation (MV) in treating acute exacerbations of chronic 
pulmonary obstructive disease (COPD) and cardiogenic pulmonary edema. Furthermore, the risk 
of complication from NPPV is much lower than MV, in terms of ventilator-associated 
pneumonia and sepsis.  
It is imperative for the nurse to understand the various indications, interfaces, and 
potential complications associated with NPPV use. In addition to treating acute exacerbations of 
COPD and cardiogenic pulmonary edema, NPPV has been used for prevention of reintubation, 
palliative care, and status asthmaticus. Furthermore, NPPV could be delivered through various 
interfaces, such as nasal, facial, and helmet. Each of these interfaces could eventually cause 
complications for the patient, such as skin ulceration and sepsis.  
However, there is limited amount of research available discussing the role of the nurse in 
caring for the patient with NPPV. There are no standardized guidelines established to assist the 
nurse in this care, in terms of interface selection, prevention of complications, and staffing 
patterns. 
Several recommendations are presented at the end of this thesis to guide future nursing 
research, education, and clinical practice, such as exploring the role of oral care and education 
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 Acute respiratory failure refers to the body’s inability to meet ventilatory demands, often 
seen in severe exacerbations of asthma and pneumonia. Difficulties in gas exchange may result 
in numerous complications, such as damage to vital organs (e.g. heart) and respiratory arrest, 
within a matter of minutes to hours. Often seen in combination, respiratory failure could be 
either hypoxemic or hypercapnic. Hypoxemic respiratory failure refers to difficulties in oxygen 
exchange (defined as PaO2< 60 mm Hg on 60% O2), while hypercapnic respiratory failure refers 
to inadequate carbon dioxide removal (defined as PaCO2> 45 mm Hg and pH <7.35) (Arbour, 
2011). 
Treatment for acute respiratory failure often involves the application of supplemental 
oxygen, mobilization of secretions, and pharmacological therapy. Oxygen is delivered through a 
nasal cannula to provide immediate oxygen to the patient. Additionally, it is imperative to 
mobilize secretions that may contribute to respiratory distress through chest physiotherapy and 
airway suctioning (Arbour, 2011). Reduction of airway inflammation and congestion could be 
provided through pharmacological therapies, such as bronchodilators and diuretics (Arbour, 
2011). If not successfully treated, mechanical ventilation is often the next course of action. 
The use of mechanical ventilation is often warranted for patients with acute respiratory 
failure in acute care settings, such as the intensive care unit (ICU) (Pierce & Sole, 2009).  
Historically, invasive mechanical ventilation (MV) had been used to maintain adequate 
respiratory levels. However, numerous complications have been reported through the use of MV, 
such as barotrauma, ventilator-associated pneumonia (VAP), and aspiration of gastric contents 
(Pierce & Sole, 2009). These complications, especially VAP, often result in prolonged hospital 
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stays, while requiring extensive care by health care personnel (Restrepo et al., 2010).  
 With the various complications associated with MV, many physicians and respiratory 
therapists have successfully used non-invasive positive pressure ventilation (NPPV) in place of 
MV to assist certain patient populations with certain forms of respiratory distress, such as COPD. 
NPPV involves the simultaneous application of positive airway pressure and noninvasive 
continuous airway pressure without intubation (Ho & Boyle, 2000). Although its modern origins 
stem back to 1938, for treatment of acute pulmonary edema and asthma, its popularity in use in 
acute care settings did not begin until the 1980s with the success of treating sleep apnea (Burns, 
2010).  
 During the past 20 years, much research has been completed in comparing the 
effectiveness of NPPV to MV. NPPV appears to improve pH levels and stabilize respiratory 
rates just as effective as MV without the complications often seen in the latter (Honrubia et al., 
2005). Although it has been used successfully for the treatment of sleep apnea, its use has 
drastically increased in the acute care setting to treat acute exacerbations of chronic obstructive 
pulmonary disease (COPD), acute pulmonary edema related to heart failure, and acute 
respiratory failure (Pierce & Sole, 2009). 
Problem 
 
From 1998 to 2008, the initial use of NPPV for COPD in acute care settings increased by 
462% throughout the United States (Chandra et al., 2012).  Although extensive research has 
focused on the use and complications of mechanical ventilation, there is a limited amount of 
accessible research regarding the use of NPPV in the acute care setting. Much of the current 
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research has primarily focused comparing the effectiveness of NPPV over MV, as opposed to 
focusing on its use in acute care settings (Honrubia et al., 2005).  
With such a drastic increase in the use of NPPV to treat COPD, it is crucial for the nurses 
in the acute setting to be able to understand, utilize, and identify any potential complications, 
such as pulmonary barotrauma and skin breakdown associated with this treatment (Burns, 2010).   
Purpose 
 
 The purpose of this thesis is to provide a comprehensive literature review of research 
findings about the various types of NPPV and its uses in acute care. Furthermore, findings 
regarding complications, as well as potential causes of failure of this treatment, will be analyzed 
to establish the role of the nurse in caring for these patients. Clinical recommendations for nurses 
will be provided at the end of this thesis. 
Method 
  
An integrated literature review was conducted to analyze the indications, complications, 
and role of the nurse in caring for patients receiving NPPV. Databases, such as Cumulative Index 
to Nursing and Allied Health Literature (CINAHL), EBSCOhost Medline, and Cochrane 
Systematic Reviews, were consulted.  Search terms, such as noninvasive positive airway 
pressure or NPPV, continuous positive airway pressure (CPAP), bilevel positive airway pressure 
(BiPap), complications, and nursing care, were utilized.  
Inclusion factors for the literature review include adult patients, ICU/ED, acute   
exacerbations of COPD, pulmonary edema related to heart failure, and ARF. Exclusion factors 





Searched databases: CINAHL, 
MEDLINE, and Cochrane 
Databases. 
Using Key terms: 
 
“NPPV” OR “noninvasive positive 
pressure ventilation” OR “BiPAP” 
OR “CPAP” 
         AND 
  “complications” OR “nurse” 
 
Articles found n= 2141 
Include only: 
• Dates between 1990-2012 
• Research articles 
• Evidence based practice 
• Peer reviewed 
 
Studies that did not fit inclusion 
criteria or were unattainable (n=1267)  
Exclusion: 
• Pediatric Patients (<18 years of 
age) 
• Sleep Apnea 
• Chronic Respiratory Failure 
After further review of studies 
n=100  
Total studies to be reviewed (n=23).  
After further review, studies pertaining 
to NPPV in acute care settings (n=17).  





 Although its modern origins stem back to the 1980s, noninvasive ventilation (e.g. NPPV) 
has been used with varying degrees of success since the early twentieth century.  Some early 
examples of noninvasive ventilation include the pneumobelt, rocking bed, and negative pressure 
ventilation.  
In the 1930s, the pneumobelt consisted of a rubber band placed on the abdomen, which 
would inflate to help stimulate respiration (Kacmarek, 2009). A key component to its success 
involved positioning the head of bed (HOB) above 30 degrees. However, after time, it appeared 
that this device only worked on patients without existing pulmonary conditions, such as COPD.  
Another innovative device used to provide noninvasive ventilation was the rocking bed. 
The patient would alternate from in Trendelenburg position to reverse Trendelenburg 
(Kacmarek, 2009). It was believed that such change in position would assist with respiration. 
Similar to the pneumobelt, these beds would work best for patients without any preexisting 
respiratory conditions. 
Of the three forms of noninvasive ventilation, the most popular was negative pressure 
ventilation. Known as the "iron lung", negative pressure would be administered through 
chambers to assist chest walls to rise and initiate inspiration (Kacmarek, 2009).  Complications 
related to air leaks and upper airway obstruction decreased its use, prompting future research into 
its counterpart, NPPV.  
 The remaining portion of this thesis will discuss the progression of NPPV research, with 
particular emphasis on the indications for NPPV in acute care setting, its different interfaces, 





Non-invasive positive airway pressure ventilation (NPPV) involves the application of 
positive pressure to help maintain ventilation in patients with compromised respiratory function 
(Wilkins, Stoller, & Kacmarek, 2009).  The mechanism of NPPV is similar to invasive positive 
pressure mechanical ventilation (MV).  According to Mehta and Hill (2001), positive pressure is 
delivered to the lungs to increase transpulmonary pressure on inhalation, while exhalation is 
controlled by elastic recoil of the alveoli and expiratory muscles. The major difference between 
NPPV and MV is the use of interfaces. While MV involves intubation or tracheostomy, NPPV 
delivers positive pressure through a mask (e.g. oronasal and facial).  
Some of the fundamental goals of NPPV treatment include avoidance of intubation, 
decreased mortality rates, decreased incidences of ventilator-associated pneumonia (VAP), 
improved gas exchange, decreased ventilation time, and increased patient comfort (Kacmarek, 
2009).  
Modes of Delivery 
 
 NPPV is delivered via multiple modes, with the two most common being continuous 
positive airway pressure (CPAP) and bilevel positive airway pressure (BiPAP).  
CPAP. This method involves the application of simultaneous inspiratory and expiratory 
pressure during spontaneous breathing (Bucher & Seckel, 2011). It can be administered through 
endotracheal intubation or noninvasively via a facial mask. It became increasingly popular in the 
1980s when its success in treating obstructive sleep apnea and other chronic respiratory 




 BiPAP. Unlike CPAP, BiPAP involves the application of two different levels of 
pressure: higher inspiratory pressure and lower expiratory pressure with oxygen (Bucher & 
Seckel, 2011). It is administered non-invasively through a facial or nasal mask. Similar to CPAP, 
the patient receiving BiPAP must be able to spontaneously breathe to receive ventilation. 
Types of Interfaces 
 
Unlike traditional MV, NPPV is administered non-invasively through different facial 
interfaces.  Some of these interfaces include, but are not limited to, nasal, full facial, mouthpiece, 
and helmet.   
Nasal. As one of the initial masks used for NPPV, nasal masks continue to be one of the 
common masks used for this treatment (Figure 2c). Consisting of plastic, the nasal interface 
surrounds the entire nose, resting on top of the bridge of the nose (Kacmarek, 2009). It is often 
triangular or conical in shape. 
However, over time, it is reported that several complications (such as mask intolerance 
and air leakage) resulted from the use of this interface. Similar alternative, such as nasal pillows, 
helps to alleviate the discomfort often associated with the traditional nasal mask (figure 2e). 
Nasal pillows are soft cushions inserted into the nasal nares during treatment (Mehta & Hill, 
2000).  
Full Facial. Another option instead of the nasal interface is the full facial (Figure 2a). 
Also known as the oronasal mask, it covers from the bridge of the nose to around the mouth, 
while headgear and straps help to hold the mask in place.  This interface is common in acute care 





Mouthpiece. Infrequently used, mouthpieces are used during the day for ventilation 
(figure 2d). This interface fits into the mouth, without any irritation to the face. However, due to 
its placement, it is only recommended for use during the patient’s waking hours. Another 
interface must be used while the patient is asleep to prevent aspiration (Kacmarek, 2009) 
Helmet. Although not approved in the United States, the helmet interface is another 
option (figure 2f. It encloses the patient’s head into NPPV therapy, resulting in less skin 
breakdown compared to the other interfaces. The helmet is held in place by straps attached to the 
axillary region (Kacmarek, 2009). 
Selection of Interface. Regardless of interface selection, special consideration is taken in 
account to ensure the adequate fit for each patient through the use of a sizing gauge provided by 
the manufacturer (Kacmarek, 2009). This is done to prevent any complications (to be further 






Figure 2. Interfaces used during NPPV treatment. Reprinted from The Lancet, 374, Stefano Nava & Nicholas 





Indications in Acute Care 
 Potential uses of NPPV in acute care settings include, but are not limited to, acute 
respiratory failure, cardiogenic pulmonary edema related to heart failure, prevention of re-
intubation after extubation, and palliative care (Burns, 2011). Due to their chronic nature, 
obstructive sleep apnea or chronic respiratory failure will not be discussed in this thesis.  
 Recommendations set forth by the American Association of Critical Care Nurses (Burns, 
2011), Aboussouan and Ricaurte (2010), and the Canadian Medical Association (Keenan et al., 
2011) will be included for each indication. The guidelines sent by Keenan et. al (2011) uses a 
grading system to rate the effectiveness of NPPV in selected indications (1-2-no grade for 
strength of recommendation, A-D for level of quality). This grading system was created upon a 
meta-analysis of 146 randomized clinical trials. Similarly, the recommendations set by 
Aboussouan and Ricaurte (2010) are rated according to the strength of evidence for each 
indication from minimal to highly successful (option – guideline – recommended). 
Acute Respiratory Failure due to COPD . Another common indication for NPPV in 
acute care settings is for ARF. It is reported that 30% of all patients admitted to the ICU receive 
MV due to ARF (Honrubia et al., 2005).  Although there are various etiologies, the primary 
focus will be on ARF due to acute exacerbations of COPD.  
 Lightowler, Wedzicha, Elliott, and Ram (2003) conducted a meta-analysis of eight 
studies. These studies analyzed the effectiveness of NPPV (as an adjunct to conventional 
treatment) over conventional treatment  (medications and controlled oxygen) to treat an acute 
exacerbation of COPD. Of the 529 total participants, approximately half received NPPV (n=268) 
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and the other usual medical care (n=261).  Upon analysis, NPPV reduced the risk of  intubation 
(p=.42, risk reduction of 58%) and complications (p=.32, risk reduction of 68%).   
The guidelines set forth by Keenan et al (2011) strongly recommend (grade of 1A) the 
use of NPPV for ARF due to severe exacerbation of COPD as evidenced by a pH <7.35 and 
relative hypercarbia. This is further supported by the American Association of Critical Care 
Nurses (Burns, 2011) and Aboussouan & Ricaurte (2010). 
Cardiogenic Pulmonary Edema. Often seen in patients with heart failure, cardiogenic 
pulmonary edema refers to a collection of fluid in the alveoli and interstitial spaces of the lungs 
as a result of left ventricular failure (Malone, 2011).  
A study conducted by Nava et al. (2003) compared the outcomes of patients (n=130) 
receiving standard care (n=65) and NPPV via a facial mask (n=65). Although mortality and 
complication rates were insignificant between the two groups, when subdivided into hypercapnic 
patients (PaCO2> 45 mmHg), standard care patients were more likely to be intubated than NPPV 
patients. Furthermore, the respiratory status of patients receiving NPPV improved faster than that 
of the standard care.   
According to Keenan et al (2011), NPPV is strongly recommended for cardiogenic 
pulmonary edema (1A). This is further supported by the American Association of Critical Care 
Nurses (Burns, 2011) and Aboussouan & Ricaurte (2010). 
 Other Indications. Some of the other potential uses of NPPV in the acute care setting 
include, but are not limited to, prevention of reintubation, palliative care, status asthmaticus, and 
failure to wean. There has been mixed reviews about the safety and efficacy of NPPV use in 
12 
 
these situations due to the limited amount of research available (Burns, 2011; Keenan et. al, 
2011; Aboussouan & Ricaurte, 2010). 
Table 1 displays the recommendations for several indications for NPPV set forth by three 
sources. 
Table 1. Indications for NPPV  
Indication American Association of 
Critical Care Nurses 
Canadian Medical 
Association 
Aboussouan & Ricaurte 
(2011) 
ARF due to COPD Yes Yes (Grade 1A) Recommended: use in 








Yes No (Grade 2C),unless 
patient is receiving care on 
a specialized unit.  
Option: ICU 
Palliative Care Yes Not mentioned Guideline: general ward & 
RCU1 
Failure to Wean Yes No (Grade 2C)  Guideline: ICU & RCU1 
Status Asthmaticus No No recommendations due 
to limited research 
Option: ICU & RCU1 
Footnote: 1. RCU, Respiratory Care Unit 
Contraindications. Several studies have indicated that NPPV is not appropriate for 
patients with severe hypoxemia (PaO2/FiO2 <75), respiratory arrest, upper airway obstruction, 
severe acidemia, multi organ failure, recent airway surgery, or cardiac arrest (Aboussouan & 
Riccaurte, 2010).  
Complications 
 Although many of the serious complications associated with MV are significantly 
reduced in NPPV, serious complications still occur with NPPV use, such as pulmonary 
barotrauma, aspiration pneumonia, and hemodynamic changes (Mehta & Hill, 2000). However, 
mask intolerance is the one of the most common complications of this treatment. Factors that 
contribute to intolerance include excessive air leakage through the mask, discomfort, and 
feelings of claustrophobia (Burns, 2011).  
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Nasal. Although nasal masks are one of the oldest interfaces used, they often lead to 
several complications. It is reported that 30-50% of patients using this interface experience mask 
discomfort with a smaller percentage experiencing a skin rash, nasal-bridge sores, and nasal 
obstruction (Gay, 2009).  
 Facial. Some of the complications reported for this interface are mask discomfort (30-
50%), claustrophobia (10-20%), skin rash/nasal bridge sores (10-20%), and seldom, aspiration of 
vomit (Gay, 2009).  
Physical. Ferrer, Esquinas, Leon, Gonzalez, Alarcon, and Torres (2003) analyzed the 
effectiveness of NPPV via a facial mask (n=51) over oxygen therapy (n=54) in patients admitted 
for severe hypoxemic respiratory failure. Some of the complications reported reported, due to 
use of a facial mask, were moderate nasal bridge ulceration (25%), conjunctivitis (6%), and 
gastric distention (2%).  
Psychological. Torheim and Gjengedal (2009) analyzed the patient’s experience with 
mask treatment.  These patients (n=5) were admitted to critical care units due to acute 
exacerbations of COPD and received NPPV via mask interfaces. Upon analysis, some common 
themes shared among the patients included experiences of “anxiety, panic, and loss of control”, 
“regaining control and trust due to skilled help”, and the “experience of mobilizing willpower”. 
These themes appear to have presented in a sequential matter, from the start of treatment (“loss 
of control” and “anxiety”) to feeling comfortable with treatment (“regaining control”) to 
terminating treatment (“mobilizing willpower”).    
Helmet. Although not approved for use in the United States, the helmet interface is used 
throughout Europe. One of the biggest complications reported is claustrophobia. 
14 
 
  Dimech (2012) provides one of the few qualitative studies analyzing the experiences of 
patients (n=6) who underwent helmet NPPV in acute care settings for more than 12 hours at a 
time, had acute respiratory failure, and were able to survive their illness.  The major themes 
found were “entrapment,” “confusion,” “helping me breathe,” “liberation,” and “trust”.  The 
extent of each theme varied per patient due to their level of comfort with the helmet. 
Between Interfaces. Several studies have been conducted to determine whether interface 
selection made a difference in treatment and further complications.  
Oronasal vs. Nasal Mask. Kwok, McCormack, Cece, Houtchens, and Hill (2003) 
conducted a randomized controlled trial to determine whether oronasal or nasal masks made a 
difference in treatment. Patients with ARF (n=70) were divided equally into two groups: nasal or 
oronasal mask. Between the two groups, there were no significant differences in vital signs and 
improved gas exchange.  However, patients in the nasal mask group were more likely to have 
mask intolerance than the facial mask group (p=.023).  
Facial Mask vs. Helmet. Antonaglia et al. (2011) equally divided recently admitted 
patients with acute exacerbations of COPD (n=40) into two groups: mask and helmet. Patients in 
the mask group (n=20) received NPPV via a facial mask on admission. Patients selected for the 
helmet group (n=20) initially received NPPV via a facial mask on admission, but were later 
transitioned to the helmet interface after four hours.  At the end of the study, it was determined 
that mask patients were more likely to be intubated than the helmet patients (45% to 10%, p < 
0.01). However, helmet patients required longer ventilator assistance (89 hours to 62 hours, 
p<0.01) and longer lengths of stays (10 days to 7 days, p<0.01) than the mask patients. Rates of 
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sepsis, pneumonia, and metabolic complications were not significant between these two 
interfaces. 
Role of the Nurse  
 Traditionally, the care for a patient receiving NPPV has mainly been the responsibility of 
the nurse and respiratory therapist. Although initiated by a physician, the nurse is responsible for 
the daily care of the patient, in terms of patient assessment, treatment of any complications, and 
patient education. A controversial topic, which should be noted later in this section, is the 
amount of time and effort the nurses are required to provide for the patients receiving NPPV.  
 Patient Assessment. A crucial component of caring for a patient receiving NPPV 
treatment is patient assessment. Patient comfort, level of conscious, work of breathing, gas 
exchange parameters, hemodynamic status, and ventilator parameters should be high priority 
when caring for these patients (Rose & Gerdtz, 2009). A thorough respiratory assessment should 
be completed by the nurse every shift to serve as a baseline to detect any respiratory distress (e.g. 
pneumothorax) (Burns, 2011). 
Respiratory Distress. It is imperative for the nurse to watch for signs and symptoms of 
respiratory distress, such as increased respiratory rate, dyspnea, and the use of accessory muscles 
(Ho & Boyle, 2000). Treatment should be stopped immediately and a physician should be 
notified if this occurs. 
Skin Breakdown. Skin underneath the edges of the mask should be assessed every 1 to 2 
hours to detect any evidence of skin breakdown. If any breakdown should occur, a dressing 




Air Leakage. Occurring in 80-100% patients receiving NPPV, air leaks are a sign of an 
incorrectly sized mask (Mehta & Hill, 2000). The nurse should encourage the patient to close 
their mouth, use chinstraps, or change the interface. 
Air Pressure Complications. The patient receiving NPPV might complain of nasal 
congestion, sinus pain, nasal/oral dryness, and eye irritation (Mehta & Hill, 2000). In an effort to 
prevent these complications, the best fitting interface should be initially selected. Nasal saline 
sprays further assists with nasal dryness, while humidification might assist with ensuring a tight-
fit to prevent oral dryness (Parsons, Sole, & Byers, 2000). 
Patient Education. In any situation, a fundamental nursing role is patient education. It is 
imperative to explain any procedure or medication given, such as NPPV, to the patient and their 
family. Unlike intubation where the patient is often unconscious, patients receiving NPPV are 
alert and oriented. With this, patient education becomes even more paramount to reduce anxiety 
for the patient. Education should be focused on discussing the reason for treatment, explaining 
the length of treatment, and signs of possible complications (Burns, 2011).  
 Timing. The extent of the nursing care (in terms of time spent) of a patient receiving 
NPPV has been a heavily debated topic. Several studies have debated whether the extended time 
necessary for patient care on NPPV is worth the benefit of the treatment.  
A 1991 study published by Chevrolet, Jolliet, Abajo, Toussi, and Louis reported that 
patients receiving NPPV via a nasal mask (n=6) required more care and time from the nurse. 
Patients with no air flow obstruction (n=3) required less nursing care (41±9%) than patients with 
such obstruction (n=3, 91±9%), in terms of total length of treatment.  
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Hilbert et al. (2000) countered the claim presented by Chevrolet et al. (1991). After the 
first 24 hours of treatment, the time required to care for these patients was minimal (25% for 
acute exacerbation of COPD, 15% for patients with postextubation). Additionally, Honrubia et 
al. (2005) further supports this claim, stating that the nurse’s workload is only increased during 






















 Although extensively studied for its effectiveness over MV, there is much to be studied 
and analyzed to further understand the role of NPPV in the acute care setting, especially in terms 
of its indications, complications, and the role of the nurse. 
Indications 
Several studies have determined that patients with acute exacerbations of COPD or 
cardiogenic pulmonary edema due to heart failure are ideal candidates for NPPV treatment. The 
effectiveness for these two indications has been studied extensively. Furthermore, there is an 
abundance of studies comparing effectiveness of different NPPV modes (CPAP and BiPAP).  
Throughout the years, several other indications for NPPV have been suggested for use, 
such as palliative care, post-extubation, or post-operative situations. For example, this treatment 
has often been utilized as palliative care to avoid sedation and unnecessary intubation. Minimal 
research has focused solely on this use. Questions of patient quality of life and risk of 
complications are paramount in determining its benefit. 
A controversial indication for NPPV is status asthmaticus. Several sources indicate that 
NPPV is absolutely contraindicated for this condition. However, some do argue that the benefits 
of this treatment outweigh the potential complications. More research, in particular clinical trials, 
is necessary to determine the effectiveness of this treatment for this life-threatening condition.  
Complications 
Several of the complications associated with NPPV use have been identified, such as skin 
ulceration and gastric distention.  These complications are often seen as minimal compared to the 
ones more often seen in MV, such as ventilator-associated pneumonia (VAP) and death. 
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However, some of the studies analyzed indicate that VAP, septic shock, and even death were 
potential complications of NPPV. In these studies, it is difficult to conclude whether NPPV alone 
triggered these complications or a confounding variable, such as inadequate patient selection, 
was involved.   
The recommendations provided to treat these complications have been a result of clinical 
practice. There are no randomized clinical trials, in particular, that deal with which course of 
treatment is ideal to treat or prevent such complications. Is oral care necessary for these patients 
as with those on MV? Which interface should be initially chosen to minimize complications? 
Oral Care. Several studies have concluded that an oral care bundle use (e.g. frequent 
mouth washing with chlorhexidine and endotracheal suctioning) minimizes the risk of ventilator-
associated pneumonia for a patient on MV (Parsons & Sole, 2009).  However, no studies 
analyzed, within the scope of this thesis, have associated the use of an oral care bundle to NPPV.  
Interface Selection. A crucial component of NPPV treatment that should be further 
analyzed is the choice in interface. Several studies have reported that nasal masks are often the 
most troublesome, in terms of complications. When such complications do occur, it is suggested 
that the nurse change the interface to another one. However, the selection process of initially 
choosing an interface is not clearly defined. It is imperative to understand what factors contribute 
to the success of an interface, such as patient diagnosis, comorbidities, and laboratory values.  
Role of the Nurse 
The nurse plays a tremendous role in care of the patient receiving NPPV through patient 
education and assessment. However, a majority of studies analyzed within this thesis did not 
address these major nursing roles. 
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Nursing Research. Several studies have indicated that nursing practice for this treatment 
is based on the clinical experiences of previous healthcare professionals. These articles are often 
anecdotal and provide limited evidence-based practice. Furthermore, a majority of the clinical 
trials relating to NPPV are led by physicians, not including multi-disciplinary efforts.  
Clinical Practice Guidelines. There is no standardized, systematic method to address the 
needs of these patients. Often presenting in the emergency department (ED), healthcare 
professionals, especially the nurse, must be able to identify the presenting clinical signs and 
symptoms to correctly identify a patient as a candidate for NPPV. Although the physician is 
responsible for initiating the course of treatment for the patient, it is important for the nurse to 
understand such conclusions.  
Clinical practice guidelines, presented as algorithms, should be created for any healthcare 
professional to ultimately assist in deciding the best course of treatment for a patient presenting 
to the ED with respiratory distress. Sinuff, Cook, Randall, and Allen (2003) created such an 
algorithm to help guide healthcare professionals to determine the course of treatment for patients 
with ARF (as presented in figure 3, page 22). Another potential application for these algorithms 
might be to guide nursing practice for caring for patients with NPPV – from choosing the correct 
interface to addressing complications and its treatment.   
Connection to Patients. The nurse-patient relationship is a crucial aspect of the success 
of NPPV treatment. Education is a major component to this care. However, no studies analyzed 
focused on the critical aspects of this education, such as identifying potential complications, 
treatment plan, and mechanism of NPPV.  
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Another aspect of this relationship that has been questioned is the increased nursing 
workload. The article written by Chevrolet et al. (1991) stated that NPPV should not be used 
because of its increased demand on nursing time. Further studies have stated the initial 24 hours 
of treatment are the most time consuming. If such an increase in nursing workload exists, should 




    
 

























































Figure 3. Example of Clinical Practice Guideline for COPD. Reprinted from CHEST, 
123, Tasnim Sinuff, Deborah J. Cook, Jill Randall, & Christopher J. Allen, Evaluation 
of a practice guideline for noninvasive positive-pressure ventilation for acute 






 There was a limitation in the amount of articles available discussing the care of the 
patient receiving NPPV.  A majority of articles found only discussed the effectiveness of NPPV 
over MV. These articles were published over fifteen years ago.  
Interfaces 
Few studies conducted analyzed the differences between the various interfaces used for 
this treatment. It is necessary to understand the complications associated with each interface to 
assist in the initial selection. 
An aspect of NPPV treatment that has not been extensively studied is that of the patient 
experience often associated with the use of the mask and helmet interfaces.  Limited literature 
exists to describe the patient’s perception of this lengthy treatment and if any commonalities 
existed from one patient to another. Used for acute and chronic problems, it is imperative to 
understand any psychological complications that might arise from the extensive use of NPPV. 
Role of the Nurse 
Only three articles exclusively discussed the role of the nurse in NPPV treatment, such as 
patient education and assessment. These articles were often anecdotal in nature and provided 
clinical advice on the role of the nurse. Another limitation was the minimal amount of literature 
available written by nurses, especially in clinical trials. Nurses play a tremendous role in the care 








Implications for Nursing Practice 
 
 Upon analysis of seventeen articles, this literature review provides several 
recommendations to advance future nursing research, education, and clinical practice. These 
recommendations only serve as a guide for future development into understanding the role of the 
nurse in caring for the NPPV patient.  
Research 
There is a minimal amount of research available discussing the role of the nurse in NPPV 
care. Further research is necessary to understand this role and the importance of patient care, in 
terms of staffing practices and prevention of complications.  
There are no standardized guidelines available to assist nurses in this treatment process. 
Research should focus on analyzing different hospital NPPV protocols, if any exist. Rates of 
complications between these hospitals should be compared to create a standardized protocol for 
all hospitals. Through the creation of such protocols, patient outcomes will potentially be similar 
throughout the country. 
  Furthermore, the articles analyzed for this literature did not discuss patient care, such as 
if patients were allowed to take off the interfaces to eat or the necessity of oral care. Additional 
research will enable nurses to further understand the best evidence-based practice for care of 
these patients.  
Finally, nurses and registered therapists, who serve as the main caregivers of these 
patients, should complete additional research on this topic or focus of their care should be 
included in physician-led studies. It is imperative to understand these healthcare personnel’s 





            With these advances in research, there is a need to introduce these findings into nursing 
education, especially at the undergraduate level. With NPPV extending to the ED and general 
medical-surgical units, many of the healthcare personnel are novice nurses or have minimal 
experience with this treatment. It is necessary for all personnel, especially nurses and respiratory 
therapists, to have a basic understanding of how NPPV works and how to care for the patient 
with this treatment. Textbooks and educational materials should be available for all personnel to 
keep up on the advances in research in this field and any clinical recommendations.   
Clinical Practice 
 With the advances of NPPV research, it is imperative to connect these findings to clinical 
practice. Focus groups and surveys should be utilized to understand the practices that best work 
within each hospital. With the standardized clinical guidelines created previously, hospitals will 
be able to gain feedback about the efficacy of these guidelines in clinical practice. Furthermore, 
there should be creation of patient education materials (pamphlets, videos, and posters) for these 
patients and their families. It is important to include the patient in this teaching, considering that 










 NPPV is a safe alternative to MV for patients with respiratory distress. Indicated for 
several reasons, patients with acute exacerbations of COPD and cardiogenic pulmonary edema 
related to heart failure are more likely to have improvements in their respiratory status with less 
complications. Although noted for its decreased rates of complications, several complications 
still exist with NPPV use, such as skin ulceration and feelings of claustrophobia. It is imperative 
for the nurse to thoroughly assess the patient receiving NPPV, noting any potential 








































Article Participants & Study 
Design 
Intervention Details Outcome Measures Results/Key Findings Relevance/Implications 
Keenan, S.P., Sinuff, T., 
Burns, K.E., Muscedere, 
J., Kustsogiannis, J., 
Cook, D.J., ... Dodek, P. 
(2011). Clinical practice 
guidelines for the use of 
noninvasive positive-
pressure ventilation and 
noninvasive continuous 
positive pressure in the 
acute care setting. 
CMAJ, 183(3), 195-213. 
Meta-analysis of articles 
discussing NPPV in 
acute care settings to 
create clinical practice 
guidelines by a group of 






(with one numeric 
grade: 1=strong, 
2=weak, no grade = no 
recommendation; and 
one letter grade: 
A=high quality, 
B=moderate, C=low, 
D=very low) to rank the 
efficacy of each form of 
NPPV and its 
indications in acute 
setting. 
Situations that are ideal for 
the use of NPPV (receiving 
GRADE of 1A) are during 
severe exacerbations of 
COPD and cardiogenic 
pulmonary edema (when 
compared to standard 
therapy). However, 
insufficient evidence exists 
for the use of NPPV in 
asthma exacerbations, chest 
trauma, and post-operative 
settings. 
The use of NPPV in 
severe exacerbations of 
COPD and cardiogenic 
pulmonary edema are 
clearly recommended. 
Much more research, in 
particular randomized 
clinical trials, is needed 
to further explore other 
uses of NPPV in the 
acute care setting. 
Sinuff, T., Cook, D.J., 
Randall, J., & Allen, 
C.J. (2003). Evaluation 
of a practice guideline 
for noninvasive 
positive-pressure 








effectiveness of a NPPV 
practice guideline, in 
which a total of 189 
patients were enrolled 






standard care prior to 
the creation of 
practice guideline 
and post-guideline 
group (n=98) receive 






rates and mortality rates 
between the two 
groups. 
Between the two groups, 
there were no differences in 
the intubation rates. 
However, the mortality 
rates of patients in the pre-
guideline group were higher 
than the post-guideline (p= 
0.037). Furthermore, more 
patients in the post-
guideline group were 
transferred to the ICU for 
improved monitoring (65% 
to 35% in the pre-guideline 
group). 
Creating a practice 
guideline for NPPV 
improves patient 
monitoring (ICU) and 
healthcare professional 
adherence. However, 
further research is 
necessary to see if the 
benefits of transferring 
such patients to the ICU 
is greater than the risks. 
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Table 3. Clinical Trial 
Article Participants and Study 
Design 
Intervention Details Outcome Measures Results/Key Findings Relevance 
And Implications 
Antonaglia, V., Ferluga, 
M., Molino, R., 
Lucangelo, U., 
Peratoner, A., Roman-




by sequential use of 
mask and helmet versus 
mask in acute 
exacerbation of chronic 
obstructive pulmonary 
disease: A preliminary 
study. Respiration, 82, 
148-154. 
Patients admitted with 
severe exacerbation of 
COPD (n=40) were 
randomized after 2h of 
NPPV by mask into 2 
groups: mask (n=20) 
and helmet (n=20). 
Mask group (n=20) 
continued to receive 
NPPV via initial mask 
used at admission, while 
helmet group (n=20) 
transitioned from mask 
to helmet use. 
Determining intubation 
rates and its causes 
(impaired gas exchange 
or intolerance), length 
of stay, and any 
complications 






Mask (n=20) patients 
were more likely to be 
intubated than the 
helmet group (45% to 
10%, p<0.01). However, 
helmet (n=20) patients 
required longer 
ventilator assistance 
(89h to 62h, p<0.01) 
and averaged longer 
length of stays (10 to 7, 
p<0.01). Rates of sepsis, 
pneumonia, and 
metabolic complications 






mask and helmet use are 
not determining factor 
in choosing a NPPV 
interface. Research is 
necessary to determine 
the factors that cause 
mask intolerance and 
interventions that could 
be done to prevent 
incidence of such 
intolerance. 
Chevrolet, J.C., Jolliet, 
P., Abajo, B., Toussi, 
A., & Louis, M. (1991). 
Nasal positive pressure 
ventilation in patients 
with acute respiratory 
failure. Difficult and 
time-consuming 







Prospective study of 
patients (n=6) who were 
not eligible for MV, 
instead received NPPV. 
All patients received 
NPPV via nasal mask 
on a positive-pressure 
ventilation designed for 
long-term home 
ventilation (PEEP, 0 cm 
H2O; assist-control 






indications for success 
in NPPV use as well as 
the time spent caring for 
these patients on 
healthcare professionals, 
in particular, the nurse. 
Patients with no air flow 
obstruction (n=3) 
required less nursing 
care, in terms of percent 
of total time (41 ± 9%). 
Patients with air flow 
obstruction (n=3) 
required more nursing 
care (91±9%). 
Patients receiving 
NPPV with obstructive 
respiratory conditions 
require more nursing 




Article Participants and Study 
Design 
Intervention Details Outcome Measures Results/Key Findings Relevance 
And Implications 
Hilbert, G., Gruson, D., 
Vargas, F., Valentino, 
R., Portel, L., Gbikpi-
Benissan, G., & 
Cardinaud, J.P. (2000). 
Noninvasive ventilation 
for acute respiratory 
failure. Quite low time 
consumption for nurses. 
European Respiratory 
Journal, 16, 710-716. 
Prospective study of 
COPD patients (n=100) 
divided into 2 groups 
based on diagnosis: 
acute exacerbation of 





weaning from MV 
(n=42). 
All patients received 
NPPV via full face 
mask. Acute 
exacerbation patients 
(n=58) used BiPap 
ventilator, while 
hypercapnic patients 
(n=42) used same 
ventilator used for 
weaning from MV. 
Nurses were asked to 
record time spent caring 




Determining the time 
spent caring for these 
patients on nurses. 
Patients receiving 
NPPV in either group 
required minimal 
amounts of time spent 
by the nurse during the 
first 24h of initiating 
NIMV treatment (acute 
exacerbation = 25%; 
postextubation 
hypercapnic = 15%). 
The time spent caring 
for patients with NPPV 
is not as high as once 
reported in Chevrolet, 
Jolliet, Abajo, Toussi, & 
Louis (1991). 
Hilbert, G., Gruson, D., 
Vargas, F., Valentino, 
R., Portel, L., Gbikpi-
Benissan, G., & 
Cardinaud, J.P. (2000). 
Noninvasive ventilation 
for acute respiratory 
failure. Quite low time 
consumption for nurses. 
European Respiratory 
Journal, 16, 710-716. 
Prospective study of 
COPD patients (n=100) 
divided into 2 groups 
based on diagnosis: 
acute exacerbation of 





weaning from MV 
(n=42). 
All patients received 
NPPV via full face 
mask. Acute 
exacerbation patients 
(n=58) used BiPap 
ventilator, while 
hypercapnic patients 
(n=42) used same 
ventilator used for 
weaning from MV. 
Nurses were asked to 
record time spent caring 







Determining the time 
spent caring for these 
patients on nurses. 
Patients receiving 
NPPV in either group 
required minimal 
amounts of time spent 
by the nurse during the 
first 24h of initiating 
NIMV treatment (acute 
exacerbation = 25%; 
postextubation 
hypercapnic = 15%). 
The time spent caring 
for patients with NPPV 
is not as high as once 
reported in Chevrolet, 




Article Participants and Study 
Design 
Intervention Details Outcome Measures Results/Key Findings Relevance 
And Implications 
Honrubia, T., Garcia 
Lopez, F.J., Franco, N., 
Mas, M., Guevara, M., 
Daguerre, M., Alia, I., 
Algora, A., & Galdos, 
P. (2005).  Noninvasive 
vs. conventional 
mechanical ventilation 
in acute respiratory 
failure: A multicenter, 
randomized controlled 






trial, patients (n=64) in 
7 ICUs with ARF and 
met 3 of the following 
criteria (FiO2 ≤ 170; RR 
≥ 35; blood pH < 7.30, 
3-5 score on Kelly scale 
of neurologic 
dysfunction, and score 
>3 on modified scale of 
accessory respiratory 
muscle use)  were 
randomized into 2 
groups: NPPV (n=31) or 
endotracheal intubation 
and MV (n=33) 
NPPV (n=31) was 
applied via face mask 
(mode: PS plus PEEP). 
PEEP was administered 
between 5 and 10 cm 
H2O, continuously for 
1st 6h.  
 





avoidance in the NPPV 




relevance of clinical 
complications, length of 
nursing workload, and 
factors that determine 
failure of NPPV in ICUs 
were analyzed. 
Approximately 58% of 
the patients in the NPPV 
group required 
subsequent MV. In 
terms of complications, 
52% of NPPV patients 
experienced at least one, 
while 70% of MV. No 
differences were found 
comparing the nursing 
workload for caring for 
a patient in either group. 
Pneumonia and RR >35 
were crucial indicators 
of NPPV failure. 
 
 
The use of NPPV 
reduces the need of 
intubation and its 
possible complications 
in the ICU. Pneumonia 
continues to be a major 
factor in determining 
the success of NPPV. 
Kwok, H., McCormack, 
J., Cece, R., Houtchens, 
J., & Hill, N.S. (2003). 
Controlled trial of 
oronasal versus nasal 
mask ventilation in the 
treatment of acute 
respiratory failure. 
Critical Care Medicine, 
31(2), 468-478. 
A randomized, 
controlled trial, acute 
respiratory failure 
patients (n=70) who met 
study criteria (clinical: 
worsened dyspnea, 
RR>24 breaths per 
minute, & use of 
accessory muscles for 
breathing or blood gas 
values of pH<7.35, >45 
mmHg, or PaO2/FiO2 
ratio <200) were equally 
divided into two groups: 




Patients were given a 
nasal or facial mask at 
time of admission. For 
all patients, the 
ventilator mode was 
CPAP 10 cm H2O or 
BiPAP 11-12 cm H2O 
inspiratory pressure and 
4 cm H2O expiratory 
pressure . 
Determining mask 
intolerance, H, RR, 
respiratory rates, and 
intubation rates for 
patients in each group. 
Mask intolerance was 
higher in the nasal than 
the facial group (12 vs. 
4, p=0.32). There were 
no significant 
differences in success 
rates (65.7% to 48.6%), 
intubation rates, or 
mortality between the 
two groups (facial to 
nasal). 
Mask intolerance is one 
of the major differences 
between nasal and facial 
masks. More research is 
necessary to determine 
mask intolerance 
between other interfaces 
and what factors 
contribute to the high 




Article Participants and Study 
Design 
Intervention Details Outcome Measures Results/Key Findings Relevance 
And Implications 
Nava, S., Carbone, G., 
DiBattista, N., Bellone, 
A., Baiardi…& Groff, 
P. (2003). Noninvasive 
ventilation in 
cardiogenic pulmonary 
edema: A multicenter 
randomized trial. 
American Journal of 
Respiratory Critical 






edema (n=130) who met 
study criteria (severe 
ARF, dyspnea of sudden 
onset, RR > 30 
breaths/minute) were 
divided into two groups: 
control (n=65) and 
NPPV (n=65). 
The control group 
(n=65) received 
standard medical care 
(e.g. medications) plus 
oxygen. The NPPV 
group (n=65) used a full 
face mask (PEEP set at 
5 cm H2O initially, 
while inspiratory 
pressure was at 10 cm 
H2O). 
Determining the rates of 
intubation, in-hospital 
mortality, and changes 
in physiological 




between the two groups 
in terms of intubation, 
in-hospital mortality, 
and changes in 
physiological variables. 
However, when the 
groups were subdivided, 
control group patients 
who had a PaCO2 
>45mmg were more 
likely to be intubated 
than the NPPV group 
(p=0.015) 
Hypercapnic patients 
receiving standard care 
were more likely to be 
intubated.  NPPV helps 
to improve respiratory 
rate, dyspnea, and 












Table 4. Descriptive Studies 
Article Participants and Study 
Design 
Intervention Details Outcome Measures Results/Key Findings Relevance 
And Implications 
Dimech, A. (2012). 
Critical care patients’ 
experience of the helmet 
continuous positive 
airway pressure. 
Nursing in Critical 
Care, 17(1), 36-43. 
 




Interviews were given 
to patients (n=6), who 
required helmet CPAP 
>12h daily, survived 
their critical illness, and 
had acute RF. 
 
Interviews were 
conducted away from 
the critical care setting, 
in a relative’s house and 




descriptive of patient’s 
experience using helmet 
CPAP. 
Some of the common 
themes found among the 
patients (n=6) about 
their experience were 
entrapment, confusion, 
helping me breathe, 
trust, and liberation. 
It is imperative to 
further understand the 
psychological 
implications of helmet 
CPAP and the other 
interfaces used for 
NPPV. 
Torheim, H. & 
Gjengedal, E. (2009). 
How to cope with the 
mask? Experiences of 
mask treatment in 




Scandinavian Journal of 
Caring Sciences, 24, 
499-506. 




(n=5) were admitted to 
hospital to receive 
NPPV due to an acute 
exacerbation of COPD. 
Nurses (n=8) were 
experienced with this 
treatment. 
Interviews were given 
to patients a few days 
after treatment ended 
and group of 8 nurses 
were interviewed during 
a focused session 
Determining 
characteristics 
descriptive of patient’s 
experience using mask 
interface and the factors 
that nurses believe are 
essential for treatment 
success. 
Three themes common 
between all five 
patients’ experiences 
were: anxiety, panic and 
loss of control; 
regaining control and 
trust through skilled 
help; and a mobilization 
of willpower. Some of 
the issues mentioned 
within the nurses (n=8) 
are individualizing 
needs, time is vital 
during this treatment, 
and experience equates 
to competence. 
There are psychological 
issues that arise after 
extended NPPV use. It 
is necessary for nurses 








Table 5. Literature Review 




Outcome Measures Results/Key Findings Relevance 
And Implications 
Amboussouan, L.S. & 
Ricaurte, B. (2010). 
Noninvasive positive 
pressure ventilation: 
Increasing use in acute 
care. Cleveland Clinical 






Over the past 20 years, 
NPPV has increased in 
use in acute care 
settings. 
Based on analysis of this article, 
NPPV is indicated for several 
reasons in the acute care settings 
(e.g. acute respiratory failure, 
acute exacerbations of COPD, 





With its increase in use, 
it is crucial to 
understand the several 
indications for NPPV 
and their success rates. 
Bambi, S. (2009). 
Noninvasive positive 
pressure ventilation: An 
abc approach for 
advanced nursing in 
emergency departments 
and acute care settings. 
Dimensions of Critical 







Determining factors of 
NPPV success to create a 
standardized nursing 
checklist. 
Critical determinants for success 
of NPPV treatment checklist 
include airway, breathing, 
circulation, disability, drainages, 
exposure, examinations, 
emotional and education, 
extensive clinical documentation, 
family, and guiding the patient 
until the end of ED path. 
Through creating a 
standardized nursing 
checklist, it will provide 
a protocol for nurses to 
follow when initiating 
NPPV to identify any 
possible complications 
early on. 
Ho, R.P. & Boyle, M. 
(2000). Non-invasive 
positive pressure 
ventilation in acute 
respiratory failure: 
Providing competent 
care. Australian Critical 







Determining the rate in 
use of NPPV in acute 
care settings and its 
complications to apply to 
nursing care 
considerations. 
Based on analysis of this article, 
the use of NPPV in acute care has 
increased. Several of the articles 
reported lower mortality rates and 
endotracheal intubation for NPPV 
patients. Indicators of failure of 
NPPV were discussed, such as 
inability to clear secretion and 
increasing hypercarbia. 
Nurses should be attune 
to completing a 
thorough patient 









Outcome Measures Results/Key Findings Relevance and 
Implications 
Parsons, C.L., Sole, 




intubation of the heart 
failure patient. 
Dimensions of Critical 









Limited research exists 
discussing the use of 
NPPV in managing heart 
failure. 
Based on analysis of this article, 
NPPV provides an option in 
treating acute respiratory distress 
in heart failure patients. It is 
stated that much research must be 
done to test the effectiveness of 
NPPV over pharmacological 
therapies, individually and 
collectively. Furthermore, the 
different forms of NPPV and its 
indications must be studied 
further. 
NPPV provides an 
option to avoid 
intubation in acute 
distress of heart failure 
patients presenting to 
the emergency 
department. 
Rose, L. & Gerdtz, M.F. 
(2009). Review of non-





Journal of Clinical 






indications for use of 
NPPV, creation of 
strategies to prevent its 
complications, and 
determine the role of the 
nurse in caring for a 
patient with NPPV. 
Upon analysis of 37 articles, 
terminology used to describe 
NPPV was unclear. However, 
there are various modes available 
to deliver such ventilation. In 
terms of nursing practice, NPPV 
must be used with caution due to 
the increased workload. There is 
little evidence to guide staffing 
decisions. 
The role of NPPV in the 
ED must be explored 
further. The balance of 
increased workload and 









Table 6. Meta-Analysis 
Article Participants and Study 
Design 
Intervention Details Outcome Measures Results/Key Findings Relevance and 
Implications 
Lightowler, J.V., 
Wedzicha, J.A., Elliott, 
M.W., & Ram, F.S. 
(2003). Non-invasive 
positive pressure 
ventilation to treat 
respiratory failure 
resulting from 
exacerbations of chronic 
obstructive pulmonary 
disease: Cochrane 
systematic review and 
meta-analysis. BMJ, 326 
(185), 1-5. 
Meta-analysis of 8 
different controlled 
clinical trials studies 
(n=529) in which 
participants (diagnosis 
of acute exacerbation of 
COPD) were divided 
into 2 groups: NPPV 
(n=268) and control 
(usual medical care, 
n=261). 
NPPV group (n=268) 
received NPPV through 
nasal or facial mask in 
additional to 
conventional medical 
care, while the control 
group (n=261) received 




NPPV should be the 
first line of care for 
patients with acute 
exacerbations of COPD 
in the acute care setting, 
in terms of failure, 
mortality, improvement 
within 1 hour of 
treatment, and need for 
intubation. 
When comparing NPPV 
to conventional medical 
care, the relative risk for 
treatment failure was 
0.51, mortality 0.41, 




Using NPPV in addition 
to usual medical care 
provides fewer 
complications and 
greater improvement in 
patient respiration 
within the first hour 
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